Form D · Other Health Care
Cognito Therapeutics Ltd.
Cambridge, MA · CIK 0001936187
Offering snapshot reported Jul 2, 2024 · SEC filing
- Reported sold
- $10.2M Offering amount: $60M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 18, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 2, 2024 | Initial | $10,249,997 | No comparison | 3 | SEC filing |
| Nov 15, 2023 | Amendment | $108,765,300 | $55,433,273vs Jul 1, 2022 | 13 | SEC filing |
| Jul 1, 2022 | Initial | $53,332,027 | No comparison | 9 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-517621
Source: Form D, filed Jul 2, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Laura Brege | Director |
| Stephen Bruso | Director |
| Gerald Chan | Director |
| Stephen Ghiglieri | Executive |
| Jeffrey Halis | Director |
| Richard Kuntz | Director |
| Helen Liang | Director |
| Zach Malchano | Executive |
| Brent Vaughan | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
1218 Massachusetts Ave Suite 200
Cambridge, MA, 02138
Cambridge, MA, 02138